Chronic Hepatitis C
Links shared publicly online about this topic
Vertex reports superior SVR rates with telaprevir-based combination therapy in Phase 3 studies for hepatitis C
news-medical.net — “Vertex Pharmaceuticals Incorporated today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have not been treated previously. In these studies, the majority of people achieved superior sustained viral response (SVR or viral cure) rates with a telaprevir-based combination regimen, compared to current therapies, regardless of race/ethnicity or stage of liver fibrosis (factors known to limit response to current hepatitis C treatments).” View full resource at news-medical.net
Most Recently Shared on November 1, 2010 at 8:53 am By:
Vertex reports superior SVR rates with telaprevir-based combination therapy in Phase 3 studies for hepatitis C: Ve... http://bit.ly/dngmiT
Interview with the FDA on new Hepatitis C drugs | CurrentMedicine.tv
currentmedicine.tv — “July 28, 2011 The FDA's Director of new drugs, CDER, Dr. Janet Woodcock, discusses the two new drugs approved to treat, and now also cure, Hepatitis C:” View full resource at currentmedicine.tv
Most Recently Shared on July 29, 2011 at 1:30 pm By:
Healthcare Channel Health Site
New Video: FDA discusses new Hep C drugs Victrelis (boceprevir) and Incivek (telaprevir) http://t.co/6RpWLQU
CDC: All Baby Boomers Should Undergo One-Time Screening for Hepatitis C - Physician's First Watch
firstwatch.jwatch.org — “The CDC is recommending one-time testing for hepatitis C in patients born between 1945 and 1965, regardless of the patients' risk for hepatitis, according to finalized guidelines published in MMWR. Patients who test positive . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on August 16, 2012 at 10:40 pm By:
Julie Bohlen Health Executive and Active Health Library
CDC: All Baby Boomers Should Undergo One-Time Screening for Hepatitis C: http://t.co/J73bh44c #medicine #news
Two new targets could enhance the body's defenses against West Nile and hepatitis C
news-medical.net — “Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C. The targets are within the infection warning system inside living cells.” View full resource at news-medical.net
Most Recently Shared on July 31, 2012 at 6:44 am By:
Two new targets could enhance the body's defenses against West Nile and hepatitis C: Two new targets have been d... http://t.co/ZNmkxNlK
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders - Chayama - 2012 - Hepatology - Wiley Online Library
www3.interscience.wiley.com — “Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders - Chayama - 2012 - Hepatology - Wiley Online Library” View full resource at www3.interscience.wiley.com
Most Recently Shared on February 25, 2012 at 5:34 am By:
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease ... http://t.co/Lcil13Bo
Effective Approaches to HCV Screening
secure.quantiamd.com — “In this presentation, Dr. Alain Litwin discusses effective HCV screening interventions: identifying the risk factors, populations worth screening, and cost-effective screening methods. Learn about the VA as an excellent screening model, and finish with a brief discussion of referral after screening.” View full resource at secure.quantiamd.com
Most Recently Shared on July 17, 2012 at 12:27 pm By:
QuantiaMD Support and Health Social Media
Advances in the treatment of #Hepatitis C: What you can do to prepare http://t.co/JAW0XHG7
Regulators accept Merck drug for expedited review - Bloomberg
bloomberg.com — “WHITEHOUSE STATION, N.J. (AP) --" Drug developer Merck & Co. said Thursday U.S. and European regulators accepted its potential hepatitis C treatment boceprevir for expedited review.” View full resource at bloomberg.com
Most Recently Shared on January 10, 2011 at 3:43 pm By:
Raymond DuBois, MD, PhD Internist, Gastroenterologist, Health Executive, Physician, and Doctor
Regulators accept Merck drug (Hep C) for expedited review - http://t.co/IQkO5TJ
FM/CFS/ME RESOURCES - New Standard for the Treatment of Chronic Fatigue Syndrome and Fibromyalgia
fmcfsme.com — “Find in-depth Fibromyalgia (FM), Chronic Fatigue Syndrome (CFS), and Myalgic Encephalopathy (ME) information including symptoms, pain relief, and promising treatments; finding the cure with the FM/CFS/ME Survey. Resources include: FAQ's, Coping Tips, Doctor Search, Disability Attorney Database, Disability Information. Support Group Resources, Awareness Resources, Drug Information, Medical Abbreviations and Definitions.” View full resource at fmcfsme.com
Most Recently Shared on June 8, 2011 at 7:15 pm By:
Ann Childers Physician, Doctor, and Psychiatrist
New Standard for the Treatment of Chronic Fatigue Syndrome and Fibromyalgia http://ow.ly/5cIuX
COPD and Household Hazards: Cleaning Products, Dust, Fireplaces, and More
webmd.com — “Many homes harbor dust, fumes, germs, and other irritants that aggravate COPD symptoms like wheezing, coughing, shortness of breath, and chest tightness.” View full resource at webmd.com
Most Recently Shared on November 17, 2010 at 6:36 pm By:
Living With COPD: Household Hazards to Avoid: Many homes harbor dust, fumes, germs, and other irritants that agg... http://bit.ly/cZCD4n
Elsevier
ijporlonline.com — “Elsevier” View full resource at ijporlonline.com
Most Recently Shared on February 14, 2012 at 4:05 pm By:
Robert Owen, MD ENT Doctor, Physician, Doctor, and Surgeon
Medworm: Olaryngologic manifestations in children with chronic neutropenia http://t.co/xPVTg3Rk Full http://t.co/AiYtC8fY
Page Unavailable : OBGYN News
obgynnews.com — “Ob.Gyn. News Digital Network is the online destination and multimedia properties of Ob.Gyn. News, the independent news publication for the obstetrician/gynecologist. Ob.Gyn. News is the leading source of news and commentary about clinical developments in obstetrics and gynecology as well as health care policy and regulations that affect the obstetrician/gynecologist's practice. Featured content includes Master Class, edited by Dr. Charles E. Miller and Dr. E. Albert Reese, and the column Drugs, ” View full resource at obgynnews.com
Most Recently Shared on April 27, 2012 at 5:36 pm By:
Dr Robert Greene Surgeon, Reproductive Endocrinologist, Physician, Doctor, and ObGyn Physician
Hypnosis Chills Out Severe Postmenopausal Hot Flashes : OBGYN News: http://t.co/WKcPjL0m
The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis
hindawi.com — “Chlamydia trachomatis infects macrophages and epithelial cells evoking acute and chronic inflammatory conditions, which, if not controlled, may put patients at risk for major health issues such as pelvic inflammatory disease, chronic abdominal pain, and infertility. Here we hypothesized that IL-10, with anti-inflammatory properties, will inhibit inflammatory mediators that are produced by innate immune cells exposed to C. trachomatis. We used human epithelial (HeLa) cells and mouse J774 macropha” View full resource at hindawi.com
Most Recently Shared on February 20, 2012 at 9:04 am By:
The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mo... http://t.co/Z4bdtIw6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
Healthcare Channel
A multimedia source for business and policy information on the healthcare space.
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
Advertisement
